AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3055672
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg decaris weekly (150 mg for 2 successive days) for 1 month (group I)
Trial: 11156862
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg/d)
Trial: 15006009
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl patches delivering 25 microg fentanyl/h (TTS‐fentanyl)
Trial: 15006009
Drug: Paracetamol and
RxNorm normalized name: Paracetamol and tramadol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol and codeine (P/C)
Trial: 8159516
Drug: Antimicrobial agents
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial agents for otitis media
Trial: 8159516
Drug: Antibiotics for
RxNorm normalized name: ANTIBIOTICS FOR TOPICAL USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics for sinusitis
Trial: 15088527
Drug: Karinat (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Karinat (2.5 mg beta-carotene, 5 mg alpha-tocopherol, 30 mg ascorbic acid, 150 mg garlic powder, one tablet twice a day for 6 months)
Trial: 15088527
Drug: Placebo (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (one tablet twice a day for 6 months)
Trial: 8232766
Drug: RU 486
RxNorm normalized name: RUS 3108
DrugBank: RUS 3108 (DB05911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 486 (10 mg/kg, p.o. at 8.00 h)
Trial: 25850966
Drug: Cocaine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (40 mg, intravenous)
Trial: 14758376
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of ciprofloxacin drops intraoperatively
Trial: 18294482
Drug: Dalteparin treatment
RxNorm normalized name: dalteparin
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin treatment
Trial: 11251353
Drug: Continuation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation with dalteparin therapy after revascularization procedures
Trial: 9489063
Drug: Clomipramine (25‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (25‐150 mg daily)
Trial: 9489063
Drug: Dothiepin (75‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dothiepin (75‐150 mg daily)
Trial: 7871037
Drug: Diazepam (FAST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (FAST condition) - 20 mg single dose
Trial: 7871037
Drug: Diazepam (SLOW
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (SLOW condition) - 6 doses of 4 mg administered at 30-min intervals
Trial: 3544648
Drug: Oxycodone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (10 mg, intramuscular injection)
Trial: 3544648
Drug: Diclofenac (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (75 mg, intramuscular injection)
Trial: 29785686
Drug: Positive framing
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive framing group (informed that dizziness is a sign that the drug had started to work)
Trial: 25363175
Drug: Pentoxifylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (400 mg three times a day)
Trial: 25363175
Drug: Verapamil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (10 mg every other week for up to 12 sessions)
Trial: 25363175
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Pentoxifylline and Verapamil)
Trial: 15987536
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg once daily for 10 days
Trial: 12494614
Drug: Model 6944
RxNorm normalized name: Model AA 2012 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Model 6944 (small-surfaced, steroid-eluting electrode tip)
Trial: 12494614
Drug: Model 6942
RxNorm normalized name: Model AA 2012 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Model 6942 (conventional sized, steroid-eluting electrode tip)
Trial: 2562095
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml of a local anesthetic solution containing 0.5% bupivacaine and 0.15 mEq of NaHCO3 (Group I)
Trial: 23220013
Drug: i.v. busulfan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. busulfan at a dose of 11.2 mg/kg/d
Trial: 23220013
Drug: other doses
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: other doses of busulfan
Trial: 19920000
Drug: Daily school
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily school exercise lessons for 1 year
Trial: 19920000
Drug: Regular school
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular school sports twice weekly
Trial: 9990360
Drug: Calcipotriol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol treatment for 4 and 7 days
Trial: 8615060
Drug: Calcipotriol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol treatment
Trial: 8090631
Drug: Oral treatment
RxNorm normalized name: Other agents for local oral treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral treatment of hyperthyroidism (0.81 GBq)
Trial: 8090631
Drug: Oral treatment
RxNorm normalized name: Other agents for local oral treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral treatment of differentiated thyroid cancer (1.85 GBq)
Trial: 17985826
Drug: Aquaphor Original
RxNorm normalized name: Aquaphor Original Severely Dry Skin 41% Topical Ointment
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aquaphor Original Emollient Ointment
Trial: 16131946
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (pharmacotherapy and psychotherapy)
Trial: 7594099
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (specific agent not mentioned); administered during menstruation.
Trial: 2178930
Drug: Oral isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral isosorbide 5-mononitrate (ISMN)
Trial: 378053
Drug: Intranasal corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal corticosteroid aerosol (beclomethasone dipropionate)
Trial: 27993169
Drug: Standardized exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized exercise prescription (HRR)
Trial: 12012144
Drug: Test product
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test product (60 mg) under fasted conditions
Trial: 10523801
Drug: 1600 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 mg/d oral clodronate
Trial: 2140330
Drug: Josamycin 1000
RxNorm normalized name: josamycin
DrugBank: Josamycin (DB01321)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Josamycin 1000 mg twice daily for a maximum of 14 days
Trial: 21192153
Drug: OROS methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS methylphenidate (36 mg/d to 108 mg/d)
Trial: 7755380
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy with adreno-oophorectomy
Trial: 7755380
Drug: Chemo-endocrine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemo-endocrine therapy with FAC
Trial: 7910470
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg suriclone
Trial: 6968611
Drug: Bulk laxative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bulk laxative and a large anal dilator
Trial: 6968611
Drug: Bulk laxative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bulk laxative only
Trial: 16032934
Drug: HFA‐BDP 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA‐BDP 160 mcg twice daily
Trial: 10653204
Drug: Clonazepam 1
RxNorm normalized name: clonazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 1 mg and Placebo (CZ + PL)
Trial: 10653204
Drug: Clonazepam 1
RxNorm normalized name: clonazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 1 mg and Sertraline 100 mg (CZ + SR)
Trial: 8559528
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (PGE2) tablets (3 mg)
Trial: 8559528
Drug: Oxytocin (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin (continuous intravenous drip)
Trial: 6880563
Drug: Chlorpropamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpropamide (250 mg) administered once
Trial: 6880563
Drug: Repeated administrations
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated administrations of chlorpropamide (250 mg b.i.d. for 2 days)
Trial: 6880563
Drug: Metergoline (antiserotonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metergoline (antiserotonin agent) and bromocriptine (dopamine-agonist)
Trial: 22192246
Drug: saxagliptin +
RxNorm normalized name: Saxagliptin
DrugBank: Saxagliptin (DB06335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: saxagliptin + metformin XR 1500 mg
Trial: 22192246
Drug: uptitrated metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: uptitrated metformin XR 2000 mg
Trial: 12325487
Drug: 2 tablets
RxNorm normalized name: Voydeya 150 MG Dose Card Pack, 4 Blister Cards, 42 Tablets Each
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 tablets of 150 mg APD
Trial: 10404554
Drug: Daily cigarette
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily cigarette consumption scenarios with varying nicotine concentrations
Trial: 1974070
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg alpidem
Trial: 1974070
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg alpidem
Trial: 2883214
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg alpidem
Trial: 29963684
Drug: Topical aminolaevulinic
RxNorm normalized name: aminolevulinate Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical aminolaevulinic acid-photodynamic therapy with green light
Trial: 29963684
Drug: Topical aminolaevulinic
RxNorm normalized name: aminolevulinate Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical aminolaevulinic acid-photodynamic therapy with red light
Trial: 21684602
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy in female participants
Trial: 2906017
Drug: Celiprolol, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol, 400 mg once daily
Trial: 24564933
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d prednisone added to MTX-based tight control strategy
Trial: 22616908
Drug: Sitafloxacin (STFX)
RxNorm normalized name: Finafloxacin
DrugBank: Sitafloxacin (DB13261)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sitafloxacin (STFX) 100 mg/day for 5 days
Trial: 15702819
Drug: Fluticasone (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone (250 microg twice daily)
Trial: 2816875
Drug: Ranitidine 100
RxNorm normalized name: ranitidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 100 mg/6 h
Trial: 2816875
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg/4 h
Trial: 2816875
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of ranitidine 0.2 mg/kg/h
Trial: 2816875
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of cimetidine 100 mg/h
Trial: 31455249
Drug: 8 mL
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mL ropivacaine 0.75%
Trial: 31455249
Drug: 16 mL
RxNorm normalized name: 16 ML Mvasi 25 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mL ropivacaine 0.75%
Trial: 31455249
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (8 mL and 16 mL)
Trial: 23736966
Drug: Voclosporin (VCS)
DrugBank: Voclosporin (DB11693)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Voclosporin (VCS) 3.0 mg/kg
Trial: 19520544
Drug: Ropivacaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (20 mL)
Trial: 19520544
Drug: Saline (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (20 mL, Control)
Trial: 17848841
Drug: Reference rhGH
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference rhGH preparation
Trial: 11831591
Drug: Dialysate with
RxNorm normalized name: Dialyvite 800 with Zinc Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate with a glucose concentration of 5.5 mmol/L
Trial: 11831591
Drug: Dialysate with
RxNorm normalized name: Dialyvite 800 with Zinc Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate with a glucose concentration of 11 mmol/L
Trial: 2966139
Drug: Flucloxacillin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flucloxacillin (500 mg qds for five days) and Tobramycin (1.5 mg/kg initially then 80 mg tds for three days)
Trial: 329948
Drug: Atenolol, Bendrofluazide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol, Bendrofluazide, and Hydralazine (twice daily)
Trial: 329948
Drug: Atenolol and
RxNorm normalized name: atenolol and thiazides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol and Bendrofluazide (once daily)
Trial: 17610527
Drug: PC-SOD 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-SOD 20 mg
Trial: 17610527
Drug: PC-SOD 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-SOD 40 mg
Trial: 17610527
Drug: PC-SOD 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-SOD 80 mg
Trial: 31599225
Drug: PC-SOD 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-SOD 160 mg
Trial: 18676075
Drug: Pravastatin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin, 40 mg/d
Trial: 273021
Drug: Sequential t
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential t test
Trial: 21055502
Drug: 30 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 μg HA
Trial: 21055502
Drug: 15 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 μg HA
Trial: 16464538
Drug: Hyperfractionated and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperfractionated and accelerated radiochemotherapy (RCT) with 5-fluorouracil (600 mg/m²/day) and carboplatin (70 mg/m²/day) on Days 1-5 and 29-33, total RT dose of 69.9 Gy in 38 days.
Trial: 9071477
Drug: Tiludronate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiludronate (400 mg/day orally)
Trial: 29053230
Drug: Group 4:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 4: One‐off face‐to‐face biofeedback treatment
Trial: 20054669
Drug: Response-oriented individualized
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Response-oriented individualized induction therapy with idarubicin (IDR) and cytarabine (Ara-C).
Trial: 20054669
Drug: Fixed-schedule induction
RxNorm normalized name: Humalog Mix Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-schedule induction therapy with idarubicin (IDR) and cytarabine (Ara-C).
Trial: 12399761
Drug: 308-nm excimer
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 308-nm excimer laser treatment, 3 times per week for up to 8 weeks
Trial: 15313811
Drug: 308-nm excimer
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 308-nm excimer laser treatment
Trial: 10435212
Drug: Lorazepam (LO)
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lorazepam (LO) 2 mg
Trial: 10435212
Drug: Oxazepam (OX)
RxNorm normalized name: Oxazepam
DrugBank: Oxazepam acetate (DB14672)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxazepam (OX) 60 mg
Trial: 24938661
Drug: Iosimenol injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iosimenol injection
Trial: 24938661
Drug: Iodixanol injection
RxNorm normalized name: Iodixanol
DrugBank: Iodixanol (DB01249)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodixanol injection
Trial: 14507232
Drug: Botox® (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botox® (total dose 20 biological units)
Trial: 24114400
Drug: Calcium citrate
RxNorm normalized name: Calcium Citrate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium citrate 1 g/day
Trial: 26307050
Drug: Intracytoplasmic morphologically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic morphologically selected sperm injection (IMSI)
Trial: 15900109
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at dosages of 4 IU/m2/day, 6 IU/m2/day, or 8 IU/m2/day for a mean duration of 7.1 (0.4) years.
Trial: 8593549
Drug: Fortified milk
RxNorm normalized name: Fortified milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified milk (12 micrograms vitamin D3 and 1525 mg calcium per litre)
Trial: 8593549
Drug: Unfortified milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfortified milk (0.3 micrograms vitamin D3 and 1270 mg calcium per litre)
Trial: 337903
Drug: Oral methoxsalen
RxNorm normalized name: Methoxsalen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methoxsalen (0.6 mg/kg) and sunlight exposure
Trial: 19100304
Drug: 7-valent conjugated
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent conjugated pneumococcal vaccine (PCV7)
Trial: 19100304
Drug: 23-valent polysaccharide
RxNorm normalized name: pneumococcal 23-valent polysaccharide vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent polysaccharide vaccine (23vPPV)
Trial: 16885405
Drug: Adiponectin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adiponectin (mean +/- SD 12.8 +/- 8.0 mug/ml)
Trial: 12527148
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care program (group A)
Trial: 1739854
Drug: Memory remediation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memory remediation treatment (compensatory and executive training skills), delivered 6 hours weekly over a 2 1/2‐week period
Trial: 27652199
Drug: Minimally invasive
RxNorm normalized name: SPY Minimally Invasive Surgery (SPY-MIS) Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimally invasive SIJ fusion with triangular titanium implants (SIJF)
Trial: 21623930
Drug: Tapering TC
RxNorm normalized name: TC-6987
DrugBank: TC-6987 (DB14854)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering TC regimen (3/week for 1st month, 2/week for 2nd month, 1/week for 4th month)
Trial: 21623930
Drug: Both regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both regimens (twice weekly and tapering)
Trial: 18953611
Drug: Preoperative imatinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative imatinib (600 mg daily for 3, 5, or 7 days)
Trial: 11696123
Drug: midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam 0.5 mg.kg(‐1)
Trial: 9312763
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 mg/night
Trial: 30672432
Drug: 50% field
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% field capacity irrigation treatment
Trial: 27399956
Drug: 0.05 mL
RxNorm normalized name: xenon 0.05 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mL injection volume of abobotulinumtoxinA (10 Speywood units)
Trial: 25407349
Drug: Clinical medication
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical medication reviews (CMRs)
Trial: 18403223
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of ipratropium and albuterol (IB+ALB)
Trial: 18403223
Drug: Albuterol alone
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol alone (ALB)
Trial: 10885682
Drug: Methylphenidate (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (10, 25, 20 mg doses)
Trial: 9289443
Drug: Kliogest hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Kliogest hormone therapy
Trial: 1521669
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg mexiletine